News & Events

You are here

Asia-Pacific specialist CRO Novotech presented Australia's R&D Refund and Simplified Regulatory Environment as a Gateway to Asia at a Government and industry event in Seoul, South Korea.

18/07/16

Video Recording: Australia: Preferred Destination for Early Phase Clinical Trials

BEIJING, CHINA - 18 May 2016 | Frost & Sullivan today presented highlights from new research into why Australia is a hub for early phase clinical trials (DIA China, Beijing, May 18, 2016).  The study was supported by Novotech, Australia’s...

26/05/16

Novotech and Frost & Sullivan Present New Data at DIA China on Australia’s Edge in Early Phase Clinical Trials

BEIJING, CHINA - 18 May 2016 | Frost & Sullivan today presented highlights from new research into why Australia is a hub for early phase clinical trials (DIA China, Beijing, May 18, 2016).  The study was supported by...

26/05/16

Webinar - Navigating Oncology Trials in Asia: How a Regional CRO can Deliver on a Global Project

Worldwide, there were an estimated 14.1 million new cancer cases in 2012 (American Cancer Society). Almost half of these occur in Asia with almost one quarter of the global burden in China. The top three cancers in women are breast, lung, and...

25/02/16

Webinar - Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors

Governments in Asian countries increasingly view biomedical/life sciences industry as a key segment for future economic growth. Substantial financial support has been granted to this segment resulting in improved clinical research infrastructure...

08/01/16

Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors, Upcoming Webinar Hosted by Xtalks

 

Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors, Upcoming Webinar Hosted by Xtalks

07 January, 2016: Join industry experts from Novotech...

15/12/15

Novotech appointed Contract Research Organisation for upcoming Phase 1b/2 study of HER-Vaxx in gastric cancer

 

  • Imugene’s clinical review for HER-Vaxx is now complete
  • HER-Vaxx Phase 1b/2 in gastric cancer to start in 2016 under an IND
  • Trial design largely completed with focus on Asia
  • Imugene to...
27/11/15

NOVOGEN ENGAGES CONTRACT RESEARCH ORGANISATION TO CONDUCT CANTRIXIL PHASE 1 CLINICAL TRIAL

02/03/15

Novotech leads the fast growing Asia Pacific clinical research sector with another Frost & Sullivan "CRO BEST PRACTICE AWARD"

Sydney, Australia, February 17, 2015

Novotech, the largest Australia-based clinical CRO with offices throughout the Asia region, has just been awarded the CRO Best Practice Award for the third time in recent years by Frost...

19/01/15

Australian clinical research company expands operation in Hong Kong

Australian clinical research company expands operation in Hong Kong

Sydney-based Novotech today (January 15) announced that it...

19/12/14

SureClinical eTMF Cloud Selected by Novotech to automate and accelerate clinical operations processes

SureClinical eTMF Cloud Selected by Novotech to automate and accelerate clinical operations processes

Internationally recognized clinical research firm Novotech announces selection of...

Pages